REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 159 filers reported holding REATA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $11,551,000 | -30.6% | 114,806 | -2.4% | 0.43% | -27.9% |
| Q2 2021 | $16,651,000 | +24.0% | 117,649 | -12.7% | 0.59% | +35.2% |
| Q1 2021 | $13,432,000 | -20.0% | 134,723 | -0.8% | 0.44% | -25.9% |
| Q4 2020 | $16,791,000 | -0.5% | 135,828 | -21.6% | 0.59% | -13.1% |
| Q3 2020 | $16,882,000 | -15.2% | 173,292 | +35.8% | 0.68% | -20.5% |
| Q2 2020 | $19,914,000 | +36.7% | 127,638 | +26.5% | 0.86% | +5.0% |
| Q1 2020 | $14,568,000 | -31.7% | 100,926 | -3.3% | 0.81% | +12.7% |
| Q4 2019 | $21,332,000 | +148.4% | 104,349 | -2.4% | 0.72% | +135.2% |
| Q3 2019 | $8,588,000 | -16.6% | 106,968 | -2.0% | 0.31% | -10.2% |
| Q2 2019 | $10,297,000 | +3.9% | 109,131 | -5.9% | 0.34% | +7.2% |
| Q1 2019 | $9,908,000 | – | 115,918 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |